Girgenti Steven's most recent trade in BioAffinity Technologies Inc was a trade of 14,814 Common Stock done . Disclosure was reported to the exchange on Jan. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 14,814 | 1,080,062 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 33,784 | 1,065,248 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 8,296 | 1,031,464 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 64,848 | 0 | - | - | Stock Option (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 03 Apr 2024 | 64,848 | 1,056,606 | - | 1.2 | 75,224 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 03 Apr 2024 | 33,438 | 1,023,168 | - | 2.2 | 74,901 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Feb 2024 | 39,474 | 991,758 | - | 1.5 | 60,000 | Common Stock |
| BioAffinity Technologies Inc | Girgenti Steven | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 11,943 | 952,284 | - | 0 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.48 per share. | 01 Oct 2023 | 12,668 | 940,341 | - | 1.5 | 18,749 | Common Stock |
| BioAffinity Technologies Inc | Girgenti Steven | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.58 per share. | 01 Oct 2023 | 11,867 | 927,673 | - | 1.6 | 18,750 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 2.28 per share. | 01 Jan 2023 | 26,315 | 915,806 | - | 2.3 | 59,998 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 01 Jan 2023 | 10,245 | 889,491 | - | 1.8 | 18,748 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 01 Jan 2023 | 10,245 | 889,491 | - | 1.8 | 18,748 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.89 per share. | 01 Jan 2023 | 9,920 | 879,246 | - | 1.9 | 18,749 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 1.89 per share. | 01 Jan 2023 | 9,920 | 879,246 | - | 1.9 | 18,749 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 2.28 per share. | 01 Jan 2023 | 8,227 | 869,326 | - | 2.3 | 18,758 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 2.28 per share. | 01 Jan 2023 | 8,227 | 869,326 | - | 2.3 | 18,758 | Common Stock |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 972,957 | 0 | - | - | Series A Convertible Preferred Stock | ||
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 221,933 | 221,933 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 156,602 | 405,880 | - | 4.2 | 657,728 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 138,993 | 820,183 | - | 3.6 | 500,375 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 123,811 | 123,811 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 87,605 | 87,605 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 59,141 | 472,678 | - | 4.2 | 248,392 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 58,797 | 531,475 | - | 4.2 | 246,947 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2022 | 40,916 | 861,099 | - | - | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2022 | 40,916 | 40,916 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2022 | 40,916 | 40,916 | - | - | Non-tradeable Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 39,275 | 629,692 | - | 4.2 | 164,955 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 35,866 | 681,190 | - | 4.2 | 150,637 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 35,714 | 35,714 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 27,378 | 558,853 | - | 4.2 | 114,988 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 15,632 | 645,324 | - | 4.2 | 65,654 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 13,326 | 579,785 | - | 4.2 | 55,969 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 10,632 | 590,417 | - | 4.2 | 44,654 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 9,091 | 0 | - | - | Series A Convertible Preferred Stock | ||
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 7,657 | 7,657 | - | 4.2 | 32,159 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 7,657 | 413,537 | - | 4.2 | 32,159 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2022 | 5,952 | 5,952 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 4,912 | 563,765 | - | 4.2 | 20,630 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 2,694 | 566,459 | - | 4.2 | 11,315 | Common Stock | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2022 | 2,380 | 2,380 | - | - | Warrants (right to buy) | |
| BioAffinity Technologies Inc | Steven Girgenti | Director, Executive Chairman | 31 Aug 2022 | 1,298 | 8,955 | - | 7.7 | 9,995 | Common Stock |